A Case Study IMA Active and Medochemie have joined forces in order to achieve optimal low-dose dry powder inhalers by combining the dosator technology and …
The largest threat currently faced by humankind is the ever-rising CO2 levels in the air we breathe. In our lifetime, the CO2 level has increased …
The inhalation of dry powders is one of the oldest forms of delivering active substances via the pulmonary route. Despite the progress in DPI drug …
Individuals involved in drug development are faced with many different challenges along the process of seeking regulatory approval. Imaging plays an important role in the …
An undertaking is defined as dominant if it enjoys such a significant market position as to grant it the power to behave, to an appreciable …
IO has witnessed a long history of highs and lows. Although conventional cytokines and vaccine immunotherapies were approved for certain cancers, high toxicities, low efficacy …
Climate change is perhaps the most complex issue facing modern society, affecting every aspect of human life. According to a Lancet report, spending on climate …
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) characterised with focal confluent lesions of primary demyelination followed by diffuse …
It is no mystery to the pharmaceutical and biotech industry that between 2018 and 2023, several original reference biologics will be coming off patent. This …
Developing a medical device is no easy task and knowing where to start is the first hurdle. Spending time early on working out which is …
IPI was established by professionals with over 30 years of experience in the Pharmaceutical and Life sciences publishing sectors. Peer-Reviewed, Contemporary, Authoritative